Prehospital use of plasma: The blood bankers' perspective

Shock

Volumn 41, Issue SUPPL. 1, 2014, Pages 39-43

  Hervig, Tor ^a,h   Doughty, Heidi ^b   Ness, Paul ^c   Badloe, John F ^d   Berseus, Olle ^e   Glassberg, Elon ^f   Heier, Hans E ^g  

^a UNIVERSITY OF BERGEN   (Norway)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Central Military Hospital   (Netherlands)

^e ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^f Trauma and Combat Medicine Branch Surgeon General's HQ Israel Defense Forces   (Israel)

^g OSLO UNIVERSITY HOSPITAL   (Norway)

^h Laboratoriebygget Haukeland Universitetssykehus   (Norway)

Author keywords

hemorrhagic shock; Plasma

Indexed keywords

ACUTE LUNG INJURY; ALGORITHM; ARTICLE; BLEEDING; BLOOD BANK; BLOOD DONOR; BLOOD GROUP INCOMPATIBILITY; BLOOD SAFETY; BLOOD TRANSFUSION REACTION; EMERGENCY CARE; HEMOSTASIS; HUMAN; MILITARY MEDICINE; MILITARY SERVICE; PLASMA TRANSFUSION; RESPONSIBILITY; RESUSCITATION; BLOOD COMPONENT THERAPY; BLOOD STORAGE; BLOOD TRANSFUSION; EMERGENCY HEALTH SERVICE; EMERGENCY MEDICINE; HEMORRHAGE; HOSPITALIZATION; ORGANIZATION AND MANAGEMENT; PLASMA; PROCEDURES;

BLOOD BANKS; BLOOD COMPONENT TRANSFUSION; BLOOD PRESERVATION; BLOOD TRANSFUSION; EMERGENCY MEDICAL SERVICES; EMERGENCY MEDICINE; HEMORRHAGE; HOSPITALIZATION; HUMANS; PLASMA; RESUSCITATION;

EID: 84899492628     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000144     Document Type: Article

References (37)

1. Borgman MA, Spinella PC, Perkins JG, Grathwohl KW, Repine T, Beekley AC, Sebesta J, Jenkins D, Wade CE, Holcomb JB: The ratio of blood products affect mortality in patients receiving massive transfusion at a combat support hospital. J Trauma 63(4):805-813, 2007.
2. Maegele M, Lefering R, Paffrath T, Tjardes T, Simanski C, Bouillon B: Redblood-cell to plasma ratios during massive transfusion are associated with mortality in severe multiple injury: a retrospective analysis from the Deutsche Gesellschaft für Unfallschirugie. Vox Sang 95:112-119, 2008.
3. Shaz BH, Dente CJ, Nichoals J, MacLeod JB, Young AN, Easley K, Ling Q, Harris RB, Hillyer CD: Increased number of coagulation products in relation to red blood cell products transfused improves mortality in trauma patients. Transfusion 50:493-500, 2012.
4. Zink KA, Sambasivan CN, Holcomb JB, Chisholm G, Schreiber ME: A high ratio of plasma and platelets to packed red cells in the first 6 hours of massive transfusion improves outcomes in a large multicentre study. Am J Surg 197(5): 565-570, 2009.
5. Jansen JO, Morrison JJ, Midwinter, MJ, Doughty HA: Changes in blood transfusion practices in the UK role 3 medical treatment facility in Afghanistan, 2008-2011 [published online ahead of print 2013 Dec 24]. Transfus Med 2013.
6. Morrison JJ, Oh DuBose J, O'Reilly DJ, Russell RJ, Blackbourne LH, Midwinter MJ, Rasmussen TE: En-route care capability from point of injury impacts mortality after severe wartime injury. Ann Surg 257:(2): 330-334, 2013.
7. Holcomb JB, del Junco DJ, Fox EE, Wade CE, Cohen MJ, Schreiber MA, Alarcon LH, Bai Y, Brasel KJ, Bulger EM, et al., for the PROMMT Study Group: The Prospective, Observational, Multicenter, Major Trauma Transfusion (PROMMT) study. JAMA Surg 148(2):127-136, 2013.
8. Meyer MA, Ostrowski SR, Windeløv NA, Johansson PI: Fibrinogen concentrates for bleeding trauma patients: what is the evidence? Vox Sang 101:(3): 185-190, 2011.
9. Haywood-Watson RJ, Holcomb JB, Gonzalez EA, Peng Z, Pati S, park PW, Wang W, Zaske AM, Menge T, Kozar RA: Modulation of syndecan-1 shedding after hemorrhagic shock and resuscitation [published online ahead of print August 19, 2011]. PloS One 6(8):e23530, 2011.
10. Wataha K, Menge T, Deng X, Shah A, Bode A, Holcomb JB, Potter D, Kozar R, Spinella PC, Pati S: Spray-dried plasma and fresh frozen plasma modulate permeability and inflammation in vitro in vascular endothelial cells. Transfusion 53(Suppl 1):80S-90S, 2013.
11. Moore EE, Chin TL, Chapman MC, Gonzalez E, Moore HB, Silliman CC, Hansen KC, Sauaia A, Banerjee A. Plasma First in the Field for Postinjury Hemorrhagic Shock. Shock 41(Suppl):35-38, 2014.
12. Scalea TM, Bochicchio KM, Lumpkins K, Hess JR, Dutton R, Pyle A, Bochicchio GV: Early aggressive use of fresh frozen plasma does not improve outcome in critically injured patients. Ann Surg 248:(4): 578-584, 2008.
13. Nakstad AR, Skaga NO, Pillgram-Larsen J, Gran B, Heier HE: Trends in transfusion of trauma victims: evaluation of changes in clinical practice. Scand J Trauma Resusc Emerg Med 19;23, 2011.
14. Yang L, Stanworth S, Hopewell S, Doree C, Murphy M: Is fresh-frozen plasma clinically effective? An update of a systematic review of randomized controls. Transfusion 52(8):1673-1686, 2012.
15. Kim BD, Zelinski MD, Jenkins DH, Schiller HJ, Berns KS, Zietlow SP: The effects of pre-hospital plasma on patients with injury: a pre-hospital plasma resuscitation. J Trauma Acute Care Surg 73(2 Suppl 1):S49-S53, 2012.
16. Moore EE, Chin TL, Chapman MC, Gonzalez E, Moore HB, Silliman CC, Hansen KC, Sauaia A, Banerjee A: Plasma first in the field for postinjury hemorrhagic shock [published online ahead of print December 5, 2013]. Shock 2013.
17. Klein HG, Anstee DJ: Mollison's Blood Transfusion in Clinical Medicine. 11th ed. Blackwell Publishing, p. 461, 2005.
18. Sailliol A, Martinaud C, Cap AP, Civadier C, Clavier B, Deshayes AV, Mendes AC, Pouget T, Demazeau N, Chueca M, et al.: The evolving role of lyophilized plasma in remote damage control resuscitation in the French Armed Forces Health Service. Transfusion 53(Suppl 1):65S-71S, 2013.
19. Starkey K, Keene D, Morrison JJ, Doughty H, Midwinter MJ, Woolley T, Jansen JO: Impact of high ratios of plasma-to-red-cell-concentrate on the incidence of acute respiratory distress syndrome in UK transfused combat casualties. Shock 40(1):15-20, 2013.
20. Reesink HW, Lee J, Keller A, Dennington P, Pink J, Holdsworth R, Schennach H, Goldman M, Petraszko T, Sun J, et al: Measures to Prevent Transfusion-Induced Lung Injury (TRALI), Vox Sang WHO Expert Group: Expert consensus statement on achieving self-sufficiency in safe blood and blood products, based on voluntary non-remunerated blood donation (VNRBD). Vox Sang 103(3):231-259, 2012.
21. Flesland Ø: A comparison of complication rates based on published haemovigilance data. Intensive Care Med 33:(Suppl 1): S17-S21, 2007.
22. Council of Europe. Responsibilities of Health Authorities in the Field of Blood Transfusion. Recommendation R(88)4. Strasbourg, France: Council of Europe; 1990.
23. International Federation of Red Cross and Red Crescent Societies: Position paper: Promoting safe and sustainable blood systems. Available at: http://www.ifrc.org/en/what-we-do/health/blood-services/position-paper- promoting-safe-and-sustainable-blood-systems/. Accessed January 8, 2014.
24. International Society of Blood Transfusion: Code of Ethics. Available at: http://www.isbtweb.org/fileadmin/user-upload/ISBT-Code-of-Ethics/Code-of- ethics-new-logo-feb-2011.pdf. Accessed January 8, 2014.
25. World Health Organization. Towards Self-sufficiency in Safe Blood and Blood Products based on Voluntary Non-remunerated Donation. Global Status 2013. Geneva, Switzerland: World Health Organization; 2013.
26. Starr D: Blood: An Epic History of Medicine and Commerce. New York: Alfred A. Knopf; 1998.
27. Titmuss RM: The Gift Relationship. From Human Blood to Social Policy. Expanded and Updated Version. 1997: New York: New Press, 1997.
28. Beal RW, van Aken W: Gift or good? A contemporary examination of the voluntary and commercial aspects of blood donation. Vox Sang 63:1-5, 1992.
29. Convention for the Protection of Human Rights and Dignity of the Human Being with regard to the application of biology andmedicine: Convention on Human Rights and Biomedicine. Oviedo, 4.IV. 1997. Available at: http://conventions. coe. int/Treaty/en/Treaties/Html/164.htm. Accessed January 8, 2014.
30. De Angelis V, Breda A: Plasma-derived medicinal products self-sufficiency from national plasma: to what extent? Blood Transfus 11(Suppl 4):132-137, 2013.
31. Heier HE, Olaussen RW, Svenningsen VM: Is Norway heading for a blood supply crisis? Tidsskr Nor Legeforen 132(22):2508-2510, 2012.
32. Nilsson L, Hedner U, Nilsson IM, Robertson B: Shelf-life of bank blood and stored plasma with special reference to coagulation factors. Transfusion 23(5): 377-381, 1983.
33. Pati S, Matijevic N, Doursout MF, Ko T, Cao Y, Deng X, Kozar RA, Hartwell E, Conyers J, Holcomb JB: Protective effect of fresh frozen plasma on vascular endothelial permeability, coagulation, and resuscitation after hemorrhagic shock are time dependent and diminish between days 0 and 5 after thaw. J Trauma 69(Suppl 1):S55-S63, 2010.
34. Bux J, Dickhorner D, Scheel E: Quality of freeze-dried (lyophilized) quarantined single-donor plasma. Transfusion 53(12):3203-3209, 2013.
35. Martinaud C, Ausset S, Deshayes AV, Cauet A, Demazeau N, Sailliol A: Use of freeze-dried plasma in French intensive care unit in Afghanistan. J Trauma 71(6):1761-1764; discussion 1764-1765, 2011.
36. Glassberg E, Nadler R, Gendler S, Abramovich A, Spinella PC, Gerhardt RT, Holcomb JB, Kreiss Y: Freeze dried plasma at the point of injury-from concept to doctrine. Shock 40(6):444-450, 2013.
37. Glassberg E, Nadler R, Rasmussen TE, Abramovich A, Erlich T, Blackbourne LH, Kreiss Y: Point-of-injury use of reconstituted freeze dried plasma as a resuscitative fluid: a special report for pre-hospital trauma care. J Trauma 75(2):S111-S114, 2013.